CYP 3.64% 28.5¢ cynata therapeutics limited

deal, page-21

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    @berad

    Yes, interesting thought on the "rights" to other indications, which I think should be renegotiated once GvHD signed.
    If they only take GvHD, then those rights shouldn't just be given to Fuji, I think that right should have a yearly fee or separate contract as it discourages outsiders from directly negotiating with our board.

    worth much more now, not just a friendly gesture to get them on board first option early.

    I also don't think the 90 day should be so long, it's just too long as in Japan, now we have proven we can go straight to Phase 2, Phase 2 means much more now in Japan, and likely US.

    You have an effective Phase 3 product in Japan...with the further testing.

    So this 90 day stuff should tighten as should the first right of refusal.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
0.010(3.64%)
Mkt cap ! $50.58M
Open High Low Value Volume
27.5¢ 28.5¢ 26.5¢ $71.15K 257.2K

Buyers (Bids)

No. Vol. Price($)
4 145787 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 44 1
View Market Depth
Last trade - 14.14pm 04/10/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.